Fig. 6From: Novel design of (PEG-ylated)PAMAM-based nanoparticles for sustained delivery of BDNF to neurotoxin-injured differentiated neuroblastoma cellsCytotoxicity curves for BDNF, PAMAM-BDNF and PEG-ylated PAMAM-BDNF nanoparticles in differentiated human neuroblastoma cell line SH-SY5Y treated with the 100 µmol/L 6-OHDA neurotoxin. The control (100% viability) are cells treated with 100 µmol/L 6-OHDA only. The data represent means ± SD for 30 experimentsBack to article page